Peer-to-Peer Podcast

PROACTIVE-cme.org^™ Peer-to-Peer Podcast Series features insightful, in-depth audio commentary from a prestigious group of prostate cancer experts. Listen in for state-of-the-art information as they address timely, clinically relevant topics identified by the expert faculty.

Download iTunes®

RSS Feed

MAC

Question

					What are the risk factors for prostate cancer? How do these risk factors impact counseling strategies with patients? What are the strengths and limitations of current prostate screening tests? Explain the difference between free prostate specific antigen (PSA), PSA velocity, and the ratio of bound to free PSA. CME Activity Expired: September 9, 2010. CME credit no longer available.
					Prostate cancer mortality results from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and the European Randomized Study of Screening for Prostate Cancer were published earlier this year in the New England Journal of Medicine. What were the significant findings of these studies? What are the current guidelines on screening for prostate cancer? What are the controversies? CME Activity Expired: October 9, 2010. CME credit no longer available.
					What are the most important results from prostate cancer chemoprevention clinical trials including the Prostate Cancer Prevention Trial (PCPT), REDUCE, and SELECT trials? CME Activity Expired: November 18, 2010. CME credit no longer available.